nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Rash—Mechlorethamine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Nabilone—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Nabilone—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Nabilone—Speech disorder—Methotrexate—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Nabilone—Flushing—Bleomycin—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Nabilone—Depression—Vincristine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Nabilone—Anorexia—Fludarabine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Nabilone—Feeling abnormal—Teniposide—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Nabilone—Stomatitis—Vincristine—lymphatic system cancer	0.00336	0.00336	CcSEcCtD
Nabilone—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Nabilone—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Nabilone—Chills—Bleomycin—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Nabilone—Nausea—Mechlorethamine—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Nabilone—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Nabilone—Abdominal pain—Teniposide—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Nabilone—Body temperature increased—Teniposide—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Nabilone—Paraesthesia—Fludarabine—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Nabilone—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Nabilone—Hallucination—Carmustine—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Nabilone—Dyspnoea—Fludarabine—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Nabilone—Dyspepsia—Fludarabine—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Nabilone—Decreased appetite—Fludarabine—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Nabilone—Visual impairment—Carmustine—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Nabilone—Fatigue—Fludarabine—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Nabilone—Hallucination—Vincristine—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Nabilone—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Nabilone—Constipation—Fludarabine—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Nabilone—Pain—Fludarabine—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Nabilone—Eye disorder—Carmustine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Nabilone—Hypersensitivity—Teniposide—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Nabilone—Flushing—Carmustine—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Nabilone—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.003	0.003	CcSEcCtD
Nabilone—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Nabilone—Anaemia—Bleomycin—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Nabilone—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Nabilone—Asthenia—Teniposide—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Nabilone—Malaise—Bleomycin—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Nabilone—Pruritus—Teniposide—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Nabilone—Arrhythmia—Carmustine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Nabilone—Leukopenia—Bleomycin—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Nabilone—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Nabilone—Body temperature increased—Fludarabine—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Nabilone—Cough—Bleomycin—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Nabilone—Diarrhoea—Teniposide—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Nabilone—Chest pain—Bleomycin—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Nabilone—Myalgia—Bleomycin—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Nabilone—Coma—Methotrexate—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Nabilone—Back pain—Carmustine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Nabilone—Discomfort—Bleomycin—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Nabilone—Chills—Mitoxantrone—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Nabilone—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Nabilone—Confusional state—Bleomycin—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Nabilone—Vision blurred—Carmustine—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Nabilone—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Nabilone—Tremor—Carmustine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Nabilone—Infection—Bleomycin—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Nabilone—Anaemia—Carmustine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Nabilone—Back pain—Vincristine—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Nabilone—Vomiting—Teniposide—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Nabilone—Agitation—Carmustine—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Nabilone—Asthenia—Fludarabine—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Nabilone—Rash—Teniposide—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Nabilone—Dermatitis—Teniposide—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Nabilone—Headache—Teniposide—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Nabilone—Pruritus—Fludarabine—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Nabilone—Back pain—Mitoxantrone—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Nabilone—Leukopenia—Carmustine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Nabilone—Anorexia—Bleomycin—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Nabilone—Anaemia—Vincristine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Nabilone—Agitation—Vincristine—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Nabilone—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Nabilone—Photosensitivity—Methotrexate—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Nabilone—Hypotension—Bleomycin—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Nabilone—Diarrhoea—Fludarabine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Nabilone—Convulsion—Carmustine—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Nabilone—Hypertension—Carmustine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Nabilone—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Nabilone—Nausea—Teniposide—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Nabilone—Anaemia—Mitoxantrone—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Nabilone—Vertigo—Vincristine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Nabilone—Leukopenia—Vincristine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Nabilone—Chest pain—Carmustine—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Nabilone—Myalgia—Carmustine—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Nabilone—Anxiety—Carmustine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Nabilone—Paraesthesia—Bleomycin—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Nabilone—Malaise—Mitoxantrone—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Nabilone—Dyspnoea—Bleomycin—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Nabilone—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Nabilone—Convulsion—Vincristine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Nabilone—Hypertension—Vincristine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Nabilone—Confusional state—Carmustine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Nabilone—Decreased appetite—Bleomycin—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Nabilone—Myalgia—Vincristine—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Nabilone—Visual disturbance—Methotrexate—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Nabilone—Cough—Mitoxantrone—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Nabilone—Infection—Carmustine—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Nabilone—Vomiting—Fludarabine—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Nabilone—Convulsion—Mitoxantrone—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Nabilone—Rash—Fludarabine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Nabilone—Dermatitis—Fludarabine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Nabilone—Hypertension—Mitoxantrone—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Nabilone—Pain—Bleomycin—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Nabilone—Headache—Fludarabine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Nabilone—Tachycardia—Carmustine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Nabilone—Chest pain—Mitoxantrone—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Nabilone—Myalgia—Mitoxantrone—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Nabilone—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Nabilone—Anxiety—Mitoxantrone—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Nabilone—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Nabilone—Discomfort—Mitoxantrone—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Nabilone—Anorexia—Carmustine—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Nabilone—Infection—Vincristine—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Nabilone—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Nabilone—Confusional state—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Nabilone—Hypotension—Carmustine—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Nabilone—Nausea—Fludarabine—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Nabilone—Infection—Mitoxantrone—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Nabilone—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Nabilone—Shock—Mitoxantrone—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Nabilone—Anorexia—Vincristine—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Nabilone—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Nabilone—Body temperature increased—Bleomycin—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Nabilone—Insomnia—Carmustine—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Nabilone—Irritability—Methotrexate—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Nabilone—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Nabilone—Paraesthesia—Carmustine—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Nabilone—Mood swings—Methotrexate—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Nabilone—Hypotension—Vincristine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Nabilone—Dyspnoea—Carmustine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Nabilone—Somnolence—Carmustine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Nabilone—Anorexia—Mitoxantrone—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Nabilone—Ataxia—Methotrexate—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.002	0.002	CcSEcCtD
Nabilone—Decreased appetite—Carmustine—lymphatic system cancer	0.002	0.002	CcSEcCtD
Nabilone—Hypotension—Mitoxantrone—lymphatic system cancer	0.002	0.002	CcSEcCtD
Nabilone—Insomnia—Vincristine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Nabilone—Paraesthesia—Vincristine—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Nabilone—Constipation—Carmustine—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Nabilone—Pain—Carmustine—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Nabilone—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Nabilone—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Nabilone—Decreased appetite—Vincristine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Nabilone—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Nabilone—Somnolence—Mitoxantrone—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Nabilone—Feeling abnormal—Carmustine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Nabilone—Fatigue—Vincristine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Nabilone—Asthenia—Bleomycin—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Nabilone—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Nabilone—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Nabilone—Constipation—Vincristine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Nabilone—Pain—Vincristine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Nabilone—Pruritus—Bleomycin—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Nabilone—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Nabilone—Fatigue—Mitoxantrone—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Nabilone—Pain—Mitoxantrone—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Nabilone—Constipation—Mitoxantrone—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Nabilone—Abdominal pain—Carmustine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Nabilone—Body temperature increased—Carmustine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Nabilone—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Nabilone—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Nabilone—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Nabilone—Abdominal pain—Vincristine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Nabilone—Body temperature increased—Vincristine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Nabilone—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Nabilone—Hypersensitivity—Carmustine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Nabilone—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Nabilone—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Nabilone—Vomiting—Bleomycin—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Nabilone—Drowsiness—Methotrexate—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Nabilone—Depression—Methotrexate—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Nabilone—Rash—Bleomycin—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Nabilone—Dermatitis—Bleomycin—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Nabilone—Asthenia—Carmustine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Nabilone—Stomatitis—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Nabilone—Hypersensitivity—Vincristine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Nabilone—Epistaxis—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Nabilone—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Nabilone—Asthenia—Vincristine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Nabilone—Diarrhoea—Carmustine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Nabilone—Nausea—Bleomycin—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Nabilone—Asthenia—Mitoxantrone—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Nabilone—Dizziness—Carmustine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Nabilone—Diarrhoea—Vincristine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Nabilone—Pharyngitis—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Nabilone—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Nabilone—Vomiting—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Nabilone—Dizziness—Vincristine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Nabilone—Rash—Carmustine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Nabilone—Dermatitis—Carmustine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Nabilone—Visual impairment—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Nabilone—Headache—Carmustine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Nabilone—Eye disorder—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Nabilone—Tinnitus—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Nabilone—Vomiting—Vincristine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Nabilone—Rash—Vincristine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Nabilone—Dermatitis—Vincristine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Nabilone—Headache—Vincristine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Nabilone—Nausea—Carmustine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Nabilone—Vomiting—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Nabilone—Rash—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Nabilone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Nabilone—Chills—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Nabilone—Headache—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Nabilone—Nausea—Vincristine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Nabilone—Nausea—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Nabilone—Back pain—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Nabilone—Vision blurred—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Nabilone—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Nabilone—Anaemia—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Nabilone—Malaise—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Nabilone—Vertigo—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Nabilone—Leukopenia—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Nabilone—Cough—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Nabilone—Convulsion—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Nabilone—Chest pain—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Nabilone—Myalgia—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Nabilone—Arthralgia—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Nabilone—Discomfort—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Nabilone—Confusional state—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Nabilone—Infection—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Nabilone—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Nabilone—Anorexia—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Nabilone—Hypotension—Methotrexate—lymphatic system cancer	0.000996	0.000996	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000971	0.000971	CcSEcCtD
Nabilone—Insomnia—Methotrexate—lymphatic system cancer	0.000964	0.000964	CcSEcCtD
Nabilone—Paraesthesia—Methotrexate—lymphatic system cancer	0.000957	0.000957	CcSEcCtD
Nabilone—Dyspnoea—Methotrexate—lymphatic system cancer	0.00095	0.00095	CcSEcCtD
Nabilone—Somnolence—Methotrexate—lymphatic system cancer	0.000947	0.000947	CcSEcCtD
Nabilone—Dyspepsia—Methotrexate—lymphatic system cancer	0.000938	0.000938	CcSEcCtD
Nabilone—Decreased appetite—Methotrexate—lymphatic system cancer	0.000926	0.000926	CcSEcCtD
Nabilone—Fatigue—Methotrexate—lymphatic system cancer	0.000919	0.000919	CcSEcCtD
Nabilone—Pain—Methotrexate—lymphatic system cancer	0.000911	0.000911	CcSEcCtD
Nabilone—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000878	0.000878	CcSEcCtD
Nabilone—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000871	0.000871	CcSEcCtD
Nabilone—Abdominal pain—Methotrexate—lymphatic system cancer	0.000842	0.000842	CcSEcCtD
Nabilone—Body temperature increased—Methotrexate—lymphatic system cancer	0.000842	0.000842	CcSEcCtD
Nabilone—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000785	0.000785	CcSEcCtD
Nabilone—Asthenia—Methotrexate—lymphatic system cancer	0.000765	0.000765	CcSEcCtD
Nabilone—Pruritus—Methotrexate—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Nabilone—Diarrhoea—Methotrexate—lymphatic system cancer	0.000729	0.000729	CcSEcCtD
Nabilone—Dizziness—Methotrexate—lymphatic system cancer	0.000705	0.000705	CcSEcCtD
Nabilone—Vomiting—Methotrexate—lymphatic system cancer	0.000677	0.000677	CcSEcCtD
Nabilone—Rash—Methotrexate—lymphatic system cancer	0.000672	0.000672	CcSEcCtD
Nabilone—Dermatitis—Methotrexate—lymphatic system cancer	0.000671	0.000671	CcSEcCtD
Nabilone—Headache—Methotrexate—lymphatic system cancer	0.000668	0.000668	CcSEcCtD
Nabilone—Nausea—Methotrexate—lymphatic system cancer	0.000633	0.000633	CcSEcCtD
